In Segment A, individuals will acquire various doses and schedules of oral ABBV-744 tablet to detect Protected dosing routine. Additional individuals are going to be enrolled at the recognized monotherapy dosign routine. In Section B, members will acquire oral ruxolitinib and ABBV-744 will likely be supplied as "add-on" therapy. In https://hermanng544sdn6.blog4youth.com/profile